Kansas 2025-2026 Regular Session

Kansas House Bill HB2159

Introduced
1/30/25  
Refer
1/30/25  
Report Pass
2/17/25  
Refer
2/18/25  

Caption

Exempting law enforcement agencies who do not provide emergency opioid antagonistspursuant to the statewide protocol from the requirement to procure a physician medical director.

Impact

The implications of HB2159 are significant, particularly as it removes law enforcement agencies from the state board of pharmacy's statewide opioid antagonist protocol. This change is intended to facilitate better access to emergency opioid antagonists without the layers of bureaucratic oversight that may delay access in emergency situations. By providing a financial framework and resources to law enforcement, the bill aims to enhance immediate response efforts in overdose situations, potentially reducing mortality rates associated with opioid overdoses.

Summary

House Bill 2159 aims to establish the emergency opioid antagonists assistance grant fund to support law enforcement agencies in purchasing emergency opioid antagonists. This initiative is designed to enhance the readiness and capability of law enforcement officials to respond to opioid overdoses effectively. The bill mandates an annual transfer of $4,000,000 from the state general fund to the newly created grant fund, prioritizing smaller law enforcement agencies in the distribution of resources needed to obtain these critical life-saving medications.

Contention

Some notable points of contention regarding HB2159 may arise from its exclusion of law enforcement agencies from certain regulatory protocols. Advocates for stronger regulatory measures may argue that this could lead to inconsistencies in how emergency opioid antagonists are administered across different jurisdictions. Furthermore, the allocation of state funds primarily to small law enforcement agencies could raise questions about equity and the effectiveness of resource distribution among various agencies that are tackling the opioid crisis.

Companion Bills

No companion bills found.

Previously Filed As

KS SB287

House Substitute for SB 287 by Committee on Health and Human Services - Prohibiting a healthcare provider from administering medication, diagnostic tests or conducting ongoing behavioral health treatments to a minor in a school facility without parental consent, enacting the no patient left alone act to require medical care facilities to allow in-person visitation in certain circumstances, expanding licensure of rural emergency hospitals that meet criteria between January 2015 and December 2020 and authorizing emergency medical responders to distribute non prescription over-the-counter medications.

KS HB2390

House Substitute for HB 2390 by Committee on Public Health and Welfare - Requiring the secretary of health and environment to study drug overdose death cases and providing for the confidentiality of acquired and related records, restricting the authority of the secretary of health and environment and local health officers to prevent the introduction and spread of infectious or contagious diseases and repealing the authority of the secretary to quarantine individuals and impose associated penalties.

KS SB445

Establishing minimum training requirements for law enforcement and emergency medical services personnel on interacting with individuals with dementia.

KS SB42

House Substitute for SB 42 by Committee on Appropriations - Exempting rural emergency hospitals from the hospital provider assessment and establishing residency and other requirements for membership on a hospital board.

KS HB2438

Eliminating the instructor-coordinator's certificate requirement associated with the teaching of emergency medical services courses.

KS SB101

Providing a sales tax exemption for area agencies on aging.

KS HB2791

Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare professionals from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare professionals for providing such treatments, authorizing professional discipline against a physician who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.

KS SB233

House Substitute for SB 233 by Committee on Health and Human Services - Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare providers from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare providers for providing such treatments, requiring professional discipline against a healthcare provider who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.

KS SB267

Defining primary aggressor for domestic violence purposes and requiring law enforcement policies to direct that arrest is the preferred response only with respect to the primary aggressor.

KS HB2492

Prohibiting abortion procedures except when necessary to save the life of the pregnant woman and providing a private cause of action for civil enforcement of such prohibition.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

CA AB2256

Law enforcement agencies: opioid antagonist.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB24

Emergency response: opioid antagonist kits.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MS SB2442

Emergency Response and Overdose Prevention Act; amend to expand the distribution and use of opioid antagonists.

MS SB2336

Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.

MI HB4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23